Comparison of topical 1% Clotrimazole and Sertaconazol in treatment of erythrasma
Not Applicable
- Conditions
- erythrasma.L08.1
- Registration Number
- IRCT201202142581N3
- Lead Sponsor
- Research deputy faculty of medicine Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1- Documented erythrasma cases with no topical therapy in recent 30 days.
2- Documented erythrasma cases with no sensitivity to clotrimuzole or sertaconazol.
Exclusion crireria:
1- Patients with treated erythrasma in recent 30 days.
2- Patients with sensitivity to clotrimazole or setaconazol.
3- Any patient with systemic disorder
4- Any patients with history of drug reaction.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity. Timepoint: Every 7 days. Method of measurement: History, clinical examination.
- Secondary Outcome Measures
Name Time Method o used. Timepoint: No used. Method of measurement: No used.